Dilemma of HCV infection in renal transplant recipients

Area of Science:

• Nephrology
• Hepatology
• Virology

Background:

• Hepatitis C virus (HCV) is a primary cause of chronic liver disease in patients undergoing dialysis.
• Transmission routes include intravenous drug use and blood transfusions, with identified risk factors.
• HCV infection significantly impacts outcomes in patients with end-stage renal disease.

Purpose of the Study:

• To review the impact of renal transplantation on Hepatitis C virus infection and its complications.
• To discuss therapeutic strategies for HCV infection before and after renal transplantation.
• To evaluate the optimal immunosuppressive protocols and survival rates in kidney transplant recipients with HCV.

Main Methods:

• Literature review of studies on renal transplantation and HCV infection.
• Analysis of pre- and post-transplant management strategies for HCV.
• Comparison of outcomes based on pretransplant HCV treatment versus no treatment.

Main Results:

• Renal transplantation can influence the course of HCV infection and related complications.
• Various therapeutic options exist for managing HCV before and after kidney transplantation.
• Pretransplant management of HCV may impact graft and patient survival compared to transplantation without prior treatment.

Conclusions:

• Management of HCV infection is crucial for patients undergoing or considering renal transplantation.
• Optimizing immunosuppression and treatment strategies can improve outcomes for HCV-positive kidney transplant recipients.
• Further research is needed to refine pretransplant management protocols for enhanced patient and graft survival.